Issue 11, 2020

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents

Abstract

A series of benzene sulphonamides with good potency and selectivity against Leishmania spp. intracellular amastigotes was identified by high-throughput screening. Approximately 200 compounds were synthesized as part of a hit-to-lead optimization program. The potency of the series appears to be strongly dependent on lipophilicity, making the identification of suitable orally available candidates challenging due to poor pharmacokinetics. Despite not identifying a clinical candidate, a likely solvent exposed area was found, best exemplified in compound 29. Ongoing detailed mode-of-action studies may provide an opportunity to use target-based medicinal chemistry to overcome the issues with the current series.

Graphical abstract: Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents

Supplementary files

Article information

Article type
Research Article
Submitted
20 May 2020
Accepted
07 Aug 2020
First published
25 Aug 2020
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2020,11, 1267-1274

Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents

P. J. Koovits, M. A. Dessoy, A. Matheeussen, L. Maes, G. Caljon, L. L. G. Ferreira, R. C. Chelucci, S. Michelan-Duarte, A. D. Andricopulo, S. Campbell, J. M. Kratz, C. E. Mowbray and L. C. Dias, RSC Med. Chem., 2020, 11, 1267 DOI: 10.1039/D0MD00165A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements